142 related articles for article (PubMed ID: 11992770)
1. Structure-based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
Furet P; Imbach P; Fuerst P; Lang M; Noorani M; Zimmermann J; García-Echeverría C
Bioorg Med Chem Lett; 2002 May; 12(10):1331-4. PubMed ID: 11992770
[TBL] [Abstract][Full Text] [Related]
2. A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome.
García-Echeverría C; Imbach P; France D; Fürst P; Lang M; Noorani AM; Scholz D; Zimmermann J; Furet P
Bioorg Med Chem Lett; 2001 May; 11(10):1317-9. PubMed ID: 11392545
[TBL] [Abstract][Full Text] [Related]
3. Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
Imbach P; Lang M; García-Echeverría C; Guagnano V; Noorani M; Roesel J; Bitsch F; Rihs G; Furet P
Bioorg Med Chem Lett; 2007 Jan; 17(2):358-62. PubMed ID: 17095212
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitors; synthesis and activity of arecoline oxide tripeptide derivatives.
Marastoni M; McDonald J; Baldisserotto A; Canella A; De Risi C; Pollini GP; Tomatis R
Bioorg Med Chem Lett; 2004 Apr; 14(8):1965-8. PubMed ID: 15050638
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.
Momose I; Umezawa Y; Hirosawa S; Iinuma H; Ikeda D
Bioorg Med Chem Lett; 2005 Apr; 15(7):1867-71. PubMed ID: 15780623
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of the chymotrypsin-like activity of the 20S proteasome by 5-methoxy-1-indanone dipeptide benzamides.
Lum RT; Nelson MG; Joly A; Horsma AG; Lee G; Meyer SM; Wick MM; Schow SR
Bioorg Med Chem Lett; 1998 Feb; 8(3):209-14. PubMed ID: 9871656
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new 3-alkoxy-7-amino-4-chloro-isocoumarin derivatives as new beta-amyloid peptide production inhibitors and their activities on various classes of protease.
Bihel F; Quéléver G; Lelouard H; Petit A; Alvès da Costa C; Pourquié O; Checler F; Thellend A; Pierre P; Kraus JL
Bioorg Med Chem; 2003 Jul; 11(14):3141-52. PubMed ID: 12818677
[TBL] [Abstract][Full Text] [Related]
8. Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones.
Elofsson M; Splittgerber U; Myung J; Mohan R; Crews CM
Chem Biol; 1999 Nov; 6(11):811-22. PubMed ID: 10574782
[TBL] [Abstract][Full Text] [Related]
9. Modeling of the binding mode of a non-covalent inhibitor of the 20S proteasome. Application to structure-based analogue design.
Furet P; Imbach P; Fürst P; Lang M; Noorani M; Zimmermann J; García-Echeverria C
Bioorg Med Chem Lett; 2001 May; 11(10):1321-4. PubMed ID: 11392546
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel non-covalent inhibitors selective to the β5-subunit of the human 20S proteasome.
Xu K; Wang K; Yang Y; Yan DA; Huang L; Chen CH; Xiao Z
Eur J Med Chem; 2015 Jun; 98():61-8. PubMed ID: 26005024
[TBL] [Abstract][Full Text] [Related]
11. The core structure of TMC-95A is a promising lead for reversible proteasome inhibition.
Kaiser M; Groll M; Renner C; Huber R; Moroder L
Angew Chem Int Ed Engl; 2002 Mar; 41(5):780-3. PubMed ID: 12491334
[No Abstract] [Full Text] [Related]
12. Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells.
Fenteany G; Schreiber SL
Chem Biol; 1996 Nov; 3(11):905-12. PubMed ID: 8939705
[TBL] [Abstract][Full Text] [Related]
13. New polyhydroxy sterols: proteasome inhibitors from a marine sponge Acanthodendrilla sp.
Tsukamoto S; Tatsuno M; van Soest RW; Yokosawa H; Ohta T
J Nat Prod; 2003 Sep; 66(9):1181-5. PubMed ID: 14510593
[TBL] [Abstract][Full Text] [Related]
14. Vinyl ester-based cyclic peptide proteasome inhibitors.
Baldisserotto A; Marastoni M; Fiorini S; Pretto L; Ferretti V; Gavioli R; Tomatis R
Bioorg Med Chem Lett; 2008 Mar; 18(6):1849-54. PubMed ID: 18294845
[TBL] [Abstract][Full Text] [Related]
15. Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes.
Loidl G; Groll M; Musiol HJ; Ditzel L; Huber R; Moroder L
Chem Biol; 1999 Apr; 6(4):197-204. PubMed ID: 10099130
[TBL] [Abstract][Full Text] [Related]
16. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR
Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040
[TBL] [Abstract][Full Text] [Related]
17. Lack of proteasome active site allostery as revealed by subunit-specific inhibitors.
Myung J; Kim KB; Lindsten K; Dantuma NP; Crews CM
Mol Cell; 2001 Feb; 7(2):411-20. PubMed ID: 11239469
[TBL] [Abstract][Full Text] [Related]
18. The bovine lung 20S proteasome binding to reversible inhibitors: modulation by sodium ion.
Eleuteri AM; Angeletti M
FEBS Lett; 2003 Jul; 547(1-3):7-10. PubMed ID: 12860377
[TBL] [Abstract][Full Text] [Related]
19. Development of novel peptidomimetics containing a vinyl sulfone moiety as proteasome inhibitors.
Ettari R; Bonaccorso C; Micale N; Heindl C; Schirmeister T; Calabrò ML; Grasso S; Zappalà M
ChemMedChem; 2011 Jul; 6(7):1228-37. PubMed ID: 21506279
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and activity of tyropeptin A derivatives as potent and selective inhibitors of mammalian 20S proteasome.
Momose I; Umezawa Y; Hirosawa S; Iijima M; Iinuma H; Ikeda D
Biosci Biotechnol Biochem; 2005 Sep; 69(9):1733-42. PubMed ID: 16195592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
